Dr. Anil Abraham Joy is a Professor in the Department of Oncology, Division of Medical Oncology in the Faculty of Medicine and Dentistry at the University of Alberta and has been a Staff Medical Oncologist at the Cross Cancer Institute since 2003. 

His past appointments include being Chair for the Northern Alberta Breast Cancer Program, Provincial Chair for the Alberta Breast Cancer Program and has also served as a member of the Canadian Agency for Drugs and Technologies in Health (CADTH)[now known as Canadian Drug Agency] pan-Canadian Oncology Drug Review (pCODR) – on the Expert Review Committee (pERC).  He is the current Research Lead for the Breast Cancer Program at the Cross Cancer Institute 

Dr. Joy’s primary clinical and translational research areas include breast and thoracic malignancies.   He has ongoing interest in therapeutic and lifestyle interventional research, guideline/consensus development, global oncology/regional disparity issues, medical education, as well as promoting a culture of wellness. 

At the end of 2024, he has multiple research grants/funding (investigator initiated, non-industry) in collaboration with other basic science and/or translational researchers (CIHR, CRSP). He has over 140 publications [see: joy aa – PubMed].

He is a keen advocate for cancer prevention, diagnosis, treatment and survivorship.